The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency

被引:9
作者
Kalafat, Erkan [1 ,2 ]
Dizdar, Merve [3 ]
Turkgeldi, Engin [1 ]
Yildiz, Sule [1 ]
Keles, Ipek [1 ]
Ata, Baris [1 ,4 ]
机构
[1] Koc Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Istanbul, Turkey
[2] Middle East Tech Univ, Fac Arts & Sci, Dept Stat, Ankara, Turkey
[3] Umraniye Teaching & Res Hosp, Dept Obstet & Gynecol, Istanbul, Turkey
[4] ART Fertil Clin, Dubai, U Arab Emirates
关键词
PPOS; anti-Mullerian hormone; cryopreservation; elective; mature oocyte; yield; HORMONE ANTAGONIST;
D O I
10.3389/fendo.2021.797227
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While gonadotrophin releasing hormone (GnRH) antagonists have been the standard of pituitary suppression during ovarian stimulation for ART, progestin primed ovarian stimulation (PPOS) has emerged as an alternative. Progestins can be started simultaneously with gonadotrophins (fixed PPOS) or later in the cycle depending on follicle growth (flexible PPOS). However, the flexible and fixed PPOS regimens have not been directly compared as of yet. This was a retrospective cohort study including women with diminished ovarian reserve who underwent oocyte cryopreservation. All women underwent ovarian stimulation with a fixed 300 IU daily dose of FSH. The primary outcome was the number of MII oocyte retrieved per cycle. Secondary outcome measures included the incidence of premature LH surge (>10ng/mL) and number of follicles larger than 14mm on the day of maturation trigger. During the screening period 2 out of 97 cycles were cancelled before oocyte retrieval, one in each group yielding an overall cancelation rate of 2%. Among women who had oocyte retrieval, 65 underwent flexible and 30 fixed PPOS. At baseline women on fixed and flexible PPOS had similar age (mean difference: -2.17 years, 95% CI: -4.46 to 0.11) and serum AMH levels (mean difference: 0.10 ng/mL, 95% CI: -0.24 to 0.47). Slight imbalances between the groups were rectified with propensity score matching using age and AMH levels. The incidence of premature LH surge (RR: 1.47, 95% CI: 0.51 - 5.27, p = 0.50), follicle count larger than 14mm on hCG day (RR: 1.14, 95% CI: 0.93 - 1.42, p = 0.22), number of MII oocytes retrieved (RR: 0.95, 95% CI: 0.79 - 1.15, p = 0.61) were similar between flexible and fixed PPOS. The rate of no oocyte retrieval was same between the groups (0.0% both) but no formal estimation was possible. Flexible and fixed PPOS regimens had no appreciable differences regarding MII oocyte yield and the incidence of premature LH surges. Cycles without oocyte retrieval were rare in both groups and ultrasonographic parameters of gonadotropin response were similar. Our study suggests the performances of either progestin regimen are comparable in this group of women.
引用
收藏
页数:6
相关论文
共 8 条
[1]   Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses [J].
Ata, Baris ;
Capuzzo, Martina ;
Turkgeldi, Engin ;
Yildiz, Sule ;
La Marca, Antonio .
HUMAN REPRODUCTION UPDATE, 2021, 27 (01) :48-66
[2]   Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial [J].
Begueria, R. ;
Garcia, D. ;
Vassena, R. ;
Rodriguez, A. .
HUMAN REPRODUCTION, 2019, 34 (05) :872-880
[3]   The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation [J].
Durdag, Gulsen Dogan ;
Bektas, Gizem ;
Turkyilmaz, Esengul ;
Goktepe, Halime ;
Sonmezer, Meltem ;
Sukur, Yavuz Emre ;
Ozmen, Batuhan ;
Atabekoglu, Cem ;
Berker, Bulent ;
Aytac, Rusen ;
Sonmezer, Murat .
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2021, 22 (04) :293-299
[4]   Medroxyprogesterone acetate is a useful alternative to a gonadotropin-releasing hormone antagonist in oocyte donation: a randomized, controlled trial [J].
Giles, Juan ;
Alama, Pilar ;
Gamiz, Pilar ;
Vidal, Carmen ;
Badia, Paloma ;
Pellicer, Antonio ;
Bosch, Ernesto .
FERTILITY AND STERILITY, 2021, 116 (02) :404-412
[5]   Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles [J].
Reichman, David E. ;
Zakarin, Lauren ;
Chao, Kenny ;
Meyer, Laura ;
Davis, Owen K. ;
Rosenwaks, Zev .
FERTILITY AND STERILITY, 2014, 102 (01) :99-102
[6]   ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions [J].
Sterne, Jonathan A. C. ;
Hernan, Miguel A. ;
Reeves, Barnaby C. ;
Savovic, Jelena ;
Berkman, Nancy D. ;
Viswanathan, Meera ;
Henry, David ;
Altman, Douglas G. ;
Ansari, Mohammed T. ;
Boutron, Isabelle ;
Carpenter, James R. ;
Chan, An-Wen ;
Churchill, Rachel ;
Deeks, Jonathan J. ;
Hrobjartsson, Asbjorn ;
Kirkham, Jamie ;
Juni, Peter ;
Loke, Yoon K. ;
Pigott, Theresa D. ;
Ramsay, Craig R. ;
Regidor, Deborah ;
Rothstein, Hannah R. ;
Sandhu, Lakhbir ;
Santaguida, Pasqualina L. ;
Schunemann, Holger J. ;
Shea, Beverly ;
Shrier, Ian ;
Tugwell, Peter ;
Turner, Lucy ;
Valentine, Jeffrey C. ;
Waddington, Hugh ;
Waters, Elizabeth ;
Wells, George A. ;
Whiting, Penny F. ;
Higgins, Julian P. T. .
BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
[7]   Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve [J].
Turkgeldi, Engin ;
Yildiz, Sule ;
Cekic, Sebile Guler ;
Shakerian, Bahar ;
Keles, Ipek ;
Ata, Baris .
HUMAN FERTILITY, 2022, 25 (02) :306-312
[8]   Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology [J].
Yildiz, Sule ;
Turkgeldi, Engin ;
Angun, Berk ;
Eraslan, Alper ;
Urman, Bulent ;
Ata, Baris .
FERTILITY AND STERILITY, 2019, 112 (04) :677-683